Skip to main content

Expanding Across Borders: Partnering and Investing in Asia Pacific Countries

October 17, 2023
Imperial Ballroom
A recent article noted that the APAC biotech market is estimated to expand at a rapid compound annual growth rate of 16.8 percent up to 2028. With some of the world's most populous countries, the need for cross border collaboration and investment to treat diseases has gained more attention. Learn from investors and innovators about opportunities in the APAC region.
Takaaki Tobaru, Partner - Remiges Ventures
Benjamin Chen, Partner - Panacea Venture
Cheng Liu, Founder, President, and CEO - Eureka Therapeutics
Sally Wang Liang, Venture Partner - Viva Bioinnovator (VBI)